|
1
|
Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
|
J Immunol
|
2005
|
1.57
|
|
2
|
Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.
|
Antimicrob Agents Chemother
|
2011
|
1.45
|
|
3
|
TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis.
|
PLoS Pathog
|
2012
|
0.87
|
|
4
|
Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
|
Infect Immun
|
2007
|
0.86
|
|
5
|
In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.
|
Clin Vaccine Immunol
|
2010
|
0.84
|
|
6
|
115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
|
Immunobiology
|
2012
|
0.83
|
|
7
|
Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
|
Eur J Immunol
|
2009
|
0.81
|
|
8
|
Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages.
|
Eur J Immunol
|
2011
|
0.81
|
|
9
|
TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
|
Eur J Immunol
|
2012
|
0.80
|
|
10
|
In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
|
Exp Parasitol
|
2013
|
0.80
|
|
11
|
Antiproteolytic and leishmanicidal activity of Coccinia grandis (L.) Voigt leaf extract against Leishmania donovani promastigotes.
|
Indian J Exp Biol
|
2015
|
0.78
|
|
12
|
Protease inhibitors in potential drug development for Leishmaniasis.
|
Indian J Biochem Biophys
|
2013
|
0.77
|
|
13
|
Immunolocalization and characterization of two novel proteases in Leishmania donovani: putative roles in host invasion and parasite development.
|
Biochimie
|
2010
|
0.77
|
|
14
|
Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes.
|
Mol Biochem Parasitol
|
2006
|
0.77
|
|
15
|
Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera.
|
Mol Biochem Parasitol
|
2008
|
0.77
|
|
16
|
Identification, purification, and characterization of a secretory serine protease in an Indian strain of Leishmania donovani.
|
Mol Cell Biochem
|
2008
|
0.77
|
|
17
|
UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.
|
Glycoconj J
|
2008
|
0.76
|
|
18
|
Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production.
|
Indian J Biochem Biophys
|
2014
|
0.76
|
|
19
|
Effect of different serine protease inhibitors in validating the 115 kDa Leishmania donovani secretory serine protease as chemotherapeutic target.
|
Indian J Biochem Biophys
|
2015
|
0.76
|
|
20
|
TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection.
|
Indian J Biochem Biophys
|
2014
|
0.75
|
|
21
|
Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
|
J Antimicrob Chemother
|
2012
|
0.75
|
|
22
|
Bioactivity guided fractionation of Moringa oleifera Lam. flower targeting Leishmania donovani.
|
Indian J Exp Biol
|
2015
|
0.75
|